topiramate and glp 1 phentermine-topiramate glp-1 receptor agonists Navigating Weight Loss Medications: Long-Term Use, Discontinuation, and Maintaining Weight Loss Treatment with GLP-1 receptor agonists

GLP-1 agonists offer a dual advantage: improving glycaemic control with lower hypoglycaemia risk (when used as monotherapy) and facilitating weight management, both of which may support better long-term outcomes in this vulnerable population

But some previous clinical trials found that people lost up to 20% of their body weight while on these GLP-1 drugs

Clinical data reveals average triglyceride reductions of 2030% in patients treated with semaglutide, with greater improvements in those starting with the highest triglyceride concentrations

As energy improves and sleep steadies, skin looks fresher for a healthy glow

can be purchased directly from the company